Ambient air pollution in terms of fine and coarse particulate matter (PM2.5 and PM10) has been shown to increase adult and infant mortalities. Most studies have estimated the risk of mortalities through attributable proportions and number of excess cases with no reference to the time lost due to premature mortalities. Disability adjusted life years (DALYs) are necessary to measure the health impact of Ambient particulate matter (PM) over time. In this study, we used life-tables for three years (2014–2016) to estimate the years of life lost (YLL), a main component of DALYs, for adult mortalities (age 30+ years) and postneonatal infant mortalities (age 28+ days–1 year) associated with PM2.5 exposure and PM10 exposure, respectively. The annual average of PM2.5 and PM10 concentrations were recorded as 87.9 μg/m3 and 167.5 μg/m3, which are 8 times greater than the World Health Organization (WHO) air quality guidelines of 10 μg/m3 and 20 μg/m3, respectively. Results indicated a total of 252.18 (95% CI: 170.69–322.92) YLL for all ages with an increase of 27,474.61 (95% CI: 18,483.02–35,370.58) YLL over 10 years. The expected life remaining (ELR) calculations showed that 30- and 65-year-old persons would gain 2.34 years and 1.93 years, respectively if the current PM2.5 exposure levels were reduced to the WHO interim targets (IT-1 = 35 μg/m3). Newborns and 1-year old children may live 79.81 and 78.94 years, respectively with an increase in average life expectancy of 2.65 years if the WHO PM10 interim targets were met (IT-1 = 70 μg/m3). Sensitivity analyses for YLL were carried out for the years 2015, 2025, and 2045 and showed that the years of life would increase significantly for age groups between 30 and 85. Life expectancy, especially for the elderly (≥60 years), would increase at higher rates if PM2.5 levels were reduced further. This study can be helpful for the assessment of poor air quality represented by PM2.5 and PM10 exposures in causing premature adult mortalities and postneonatal infant mortalities in developing countries with high ambient air pollution. Information in this article adds insights to the sustainable development goals (SDG 3.9.1 and 11.6.2) related to the reduction of mortality rates attributed to ambient air levels of coarse and fine particulate matter.
Airborne nanoparticles have been studied worldwide, but little is known about their sources in the Middle East region, where hot, arid and dusty climatic conditions generally prevail. For the first time in Kuwait, we carried out size-resolved measurements of particle number distributions (PNDs) and concentrations (PNCs) in the 5-1000 nm size range. Measurements were made continuously for 31 days during the summer months of May and June 2013 using a fast-response differential mobility spectrometer (Cambustion DMS500) at a sampling rate of 10 Hz. Sources and their contributions were identified using the positive matrix factorization (PMF) approach that was applied to the PND data. Simultaneous measurements of gaseous pollutants (i.e., O3, NO, NOx, SO2 and CO), PM10, wind speed and direction were also carried out to aid the interpretation of the PMF results through the conditional probability function plots and Pearson product-moment correlations. Six major sources of PNCs were identified, contributing ∼46% (fresh traffic emissions), 27% (aged traffic emissions), 9% (industrial emissions), 9% (regional background), 6% (miscellaneous sources) and 3% (Arabian dust transport) of the total PNCs. The sources of nanoparticles and their PND profiles identified could serve as reference data to design more detailed field studies in the future and treat these sources in dispersion modelling and health impact assessment studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.